
Afayro 20 Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Afatinib dimaleate (20mg)
Overview Afayro 20 Tablet
Afayro 20mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your individual needs and may vary. Strictly adhere to your doctor's prescribed regimen; improper use or overdose can lead to severe complications. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, rash, dry skin, and diarrhea (which may be severe; manage it as directed by your doctor and maintain adequate hydration). Regular blood tests may be recommended. Photosensitivity is possible; use sunscreen and protective clothing when exposed to sunlight. Report any eye irritation (pain, redness, dryness) to your physician. Prior to commencing treatment, disclose any respiratory, hepatic, or renal conditions, or concurrent use of anti-infectives. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; women of childbearing age must employ effective contraception.
Primary Ingredients of Afayro 20 Tablet
No text provided to rephrase.
Uses of Afayro 20 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afayro 20 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Afayro 20 Tablet on an empty stomach.
Common Side effects of Afayro 20 Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afayro 20 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afayro 20 Tablet should be administered on an empty stomach.
How Afayro 20 Tablet works:
Afayro 20 Tablet is an anticancer drug that targets and blocks specific enzyme receptors (EGFR, HER2, and HER4) crucial for cancer cell proliferation. This inhibition disrupts cancer cell signaling pathways, thereby hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Afayro 20 Tablet with alcohol.
PregnancyCONSULT YOUR DOCTOR
Using Afayro 20 Tablet during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Afayro 20 Tablet. Available evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Afayro 20 Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of Afayro 20 Tablet in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afayro 20 Tablet appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Afayro 20 Tablet :
Omit any missed Afayro 20 Tablet dose and resume your usual medication regimen; avoid taking a double dose.
Facts to Know About Afayro 20 Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Type of Treatment | Cancer Drugs |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
